BeeHaus2
1 month ago
Ensysce Biosciences (NASDAQ:ENSC) has announced a $5 million concurrent registered direct offering and exercise of warrants. The company will issue and sell 3,553,194 shares of common stock at $0.47 per share. Additionally, certain outstanding warrants to purchase 7,203,504 shares will be exercised at a reduced price of $0.47 per share. In a private placement, Ensysce will issue unregistered Series A-3 and A-4 warrants to purchase up to 14,358,450 shares each. The offerings are expected to close around August 29, 2024. H.C. Wainwright & Co. is the exclusive placement agent. Ensysce plans to use the proceeds for developing its TAAP and MPAR programs and for working capital, supplementing a recent $14 million NIH grant for PF614-MPAR development.
Shift-4
1 month ago
I truthfully don't think the shorts understand any better than demoralized longs do, the power that the expiration of the GEM agreement had on the downside pressure. It's an invisible release, and it's only becoming obvious now that the bottom isn't infinite (as it's seemed for so long).
The emperor has no clothes- they're being exposed right now for continuing to play the game as it went before. But the pattern is broken, and they don't have infinite downside pressure anymore.
They're getting exposed as we speak, and I expect it to continue. It's going to take time for this stock to ripen fully, but it's so severely undervalued that even just the rebound will be highly profitable.
I maintain that this is a buyout candidate more than anything- we likely won't see it bring itself to the promised land of its full potential. But there is huge value in where we are, even now.
-$
Shift-4
1 month ago
I told you man, this is a winner. It requires patience.
I don't know what your situation is- I don't fault anyone for a good scalp. I don't. But if you have the patience to ride this (given your entry), you can do quite well for yourself here.
I fully intend to. Please feel free anytime to reach out. I don't have PM privileges outside of friday, but feel free to reply to a random post anytime and I'll give you what I've got.
I hope we all make it. I praise you for seeing a good thing at the moment few did. Props. It won't be an easy, or linear, journey. But we can generate wealth here.
-$
Invest-in-America
1 month ago
ENSC: Look out, above, Peeps!!! A TOM-BRADY-LIKE 'comeback' may be in progress for this little ENSC puppy!!! (But then, maybe NOT. Myself, I consult daily with my 'PSYCHIC HOUSE CAT', who told me WHERE this ENSC stock is going today. See said Cat, below, in action --- about 40-minutes ago --- courtesy of my new, Toilet-Selfie-Cam.)
Shift-4
4 months ago
The implications of this stock are ridiculous fundamentally speaking, but what has me intrigued is the expiration of the financing restrictions established by GEM Bahamas as a condition of Ensysce's RM with (formerly) LACQ.
The three-year terms of the financing restrictions were established in late December of 2020, but their effective date was July, 2021. It established a revolving line-of-credit with GEM, whereby the company could access up to $60M of capital by issuing shares at 90% of a preceding interval price to GEM Bahamas. This gives GEM a vested interest in shorting the stock relentlessly to ensure that any conversion would result in maximum share allocation (to them) and maximum dilution (to shareholders). The embedded restrictions severely hampered ENSC's ability to secure alternative financing.
The company has run a razor-lean operation to avoid tapping this line of credit, and has been unable to consider other financing offers while the contract is in effect. GEM has rather obviously been running a ruthless naked shorting operation to ensure that any redemption earns them maximum future profit. The July expiration of this arrangement means no more need for either, and I expected the market rebound to begin in anticipation of this. It appears to have begun; I believe it will continue. And I think the company is going to have a lot to reveal to shareholders about what they've been arranging for when the financial handcuffs come off.
There are a large number of significant developments this company could announce which would positively impact the share price. But this key issue is, I believe, the explanation for both the historic devaluation of the stock to truly absurd levels, and also why no previous runs have been sustainable. Its ending marks a new beginning for ENSC, and in my opinion an historic run when the market re-adjusts.
-$